Bonerge launched a placebo-controlled trial of StanYouth® Urolithin A focused on night shift hospital workers, assessing recovery from circadian disruption. The study supports ongoing clinical validation of its product, though the news provides no results or guidance impact yet.
Bonerge launched a placebo-controlled trial of StanYouth® Urolithin A focused on night shift hospital workers, assessing recovery from circadian disruption. The study supports ongoing clinical validation of its product, though the news provides no results or guidance impact yet.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.10
